ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1288

Predictors of Frailty Identified by the Short Physical Performance Battery and Associations with Patient-reported Outcomes

Patricia Katz1, Jinoos Yazdany2, Laura Trupin3, Stephanie Rush2, Cristina Lanata3, Lindsey Criswell4 and Maria Dall'Era5, 1University of California, San Francisco, Novato, CA, 2University of California, San Francisco, San Francisco, CA, 3UCSF, San Francisco, CA, 4Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, University of California San Francisco, San Francisco, CA, 5Division of Rheumatology, University of California, San Francisco, CA

Meeting: ACR Convergence 2020

Keywords: functional status, Patient reported outcomes, physical activity, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Comorbidities

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Frailty, defined as a generalized vulnerability to stressors, has emerged as a relevant concept in SLE1, although its origins are in geriatrics.  As defined by the Fried Frailty Phenotype (FFP)2, frailty is an aggregate of 5 constructs: weight loss, exhaustion, low physical activity, slowness, and weakness.  Other means of identifying frailty have been suggested that may be easier to implement in clinical settings, including a shorter performance-based method, the Short Physical Performance Battery (SPPB)3.  We examined the prevalence of frailty using the SPPB in a well-characterized SLE cohort.

Methods: Data are from the California Lupus Epidemiology Study (CLUES), a longitudinal cohort of individuals with rheumatologist-confirmed SLE.  Data are collected annually through in-person research visits and structured interviews.  At one visit, the SPPB was administered to a subset of the cohort.  SPPB consists of balance tests, time to complete 5 chair stands, and gait speed over 4 meters.  Scores range from 0 – 12; a score of < 10 identifies frailty.  Differences in participant characteristics for frail/not frail were examined using t-tests or chi-square analyses.  Multivariate logistic regression analyses identified independent predictors of frailty, including age, sex, race/ethnicity, l, obesity, SLE duration, SLE disease activity, and steroid use.  Separate models were constructed to include either physician-assessed (SLE Disease Activity Index, SLEDAI) or patient-reported disease activity (Systemic Lupus Activity Questionnaire).  The impact of frailty on patient-reported outcomes (PROs) was examined with multiple regression analyses.

Results: Among the 150 individual who completed the SPPB, mean age was 45 ± 14 years, disease duration 15 ± 10 years, 89% were female, 41% Asian, 25% Hispanic, 26% white non-Hispanic, and 8% African American.  The proportion of individuals classified as frail was 48% (Table 1). Factors associated with frailty in bivariate analyses were low income, obesity, physical inactivity, and patient-reported disease activity (Table 1).  In multivariate analysis, only race/ethnicity remained a significant independent predictor of frailty (Hispanic only when adjusting for SLEDAI, Hispanic and African America when adjusting for SLAQ).  In post-hoc analyses, obesity and inactivity were found to be significantly more common among Hispanics and African Americans (p< .01, not shown). Frailty was associated with worse scores on most PROs, even after adjusting for race/ethnicity, income, obesity, and physician-assessed disease activity (Table 3).

Conclusion: Using the SPPB, nearly half of this sample was identified as frail.  A previous study using the FFP found 20% prevalence of frailty and 50% pre-frailty.  Racial/ethnic differences were noted, but may be due to greater prevalence of obesity and inactivity among Hispanics and African Americans.  Patient-reported outcomes were consistently worse among individuals classified as frail, even after adjusting for covariates.  Interventions aimed at reducing inactivity may reduce frailty among individuals with SLE.

1 Katz P. Lupus Sci Med 2017;4:e000186
2 Fried L. J Gerontol 2001; 56:M146
3 Guralnik J. J Gerontol 1994; 49:M85


Disclosure: P. Katz, None; J. Yazdany, Eli Lilly, 1, Astra Zeneca, 1; L. Trupin, None; S. Rush, None; C. Lanata, None; L. Criswell, None; M. Dall'Era, Janssen, 5, AstraZeneca, 5.

To cite this abstract in AMA style:

Katz P, Yazdany J, Trupin L, Rush S, Lanata C, Criswell L, Dall'Era M. Predictors of Frailty Identified by the Short Physical Performance Battery and Associations with Patient-reported Outcomes [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/predictors-of-frailty-identified-by-the-short-physical-performance-battery-and-associations-with-patient-reported-outcomes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-frailty-identified-by-the-short-physical-performance-battery-and-associations-with-patient-reported-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology